Liu, D., Xing, J., Trink, B., & Xing, M. (2010). BRAF Mutation-selective Inhibition of Thyroid Cancer Cells by the Novel MEK Inhibitor RDEA119 and Genetic-potentiated Synergism with the mTOR Inhibitor Temsirolimus.
Citación estilo ChicagoLiu, Dingxie, Joanna Xing, Barry Trink, and Mingzhao Xing. BRAF Mutation-selective Inhibition of Thyroid Cancer Cells By the Novel MEK Inhibitor RDEA119 and Genetic-potentiated Synergism With the MTOR Inhibitor Temsirolimus. 2010.
Cita MLALiu, Dingxie, Joanna Xing, Barry Trink, and Mingzhao Xing. BRAF Mutation-selective Inhibition of Thyroid Cancer Cells By the Novel MEK Inhibitor RDEA119 and Genetic-potentiated Synergism With the MTOR Inhibitor Temsirolimus. 2010.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.